UNCY - Unicycive Therapeutics reports Q3 results November, 11 2021 09:29 AM Unicycive Therapeutics Inc. Unicycive Therapeutics (NASDAQ:UNCY): Q3 GAAP EPS of $0.37. As of September 30, 2021, cash and cash equivalents totaled $18 million. Press Release For further details see: Unicycive Therapeutics reports Q3 results